Cargando…

The Pharmacology of Gene and Cell Therapy

Detalles Bibliográficos
Autores principales:	Conlon, Thomas J., Mavilio, Fulvio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908264/ https://www.ncbi.nlm.nih.gov/pubmed/29687036 http://dx.doi.org/10.1016/j.omtm.2017.12.007

Ejemplares similares

Gene Therapy for Hemoglobinopathies
por: Cavazzana, Marina, et al.
Publicado: (2018)

Designing Lentiviral Vectors for Gene Therapy of Genetic Diseases
por: Poletti, Valentina, et al.
Publicado: (2021)

Interactions between Retroviruses and the Host Cell Genome
por: Poletti, Valentina, et al.
Publicado: (2017)

Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency
por: Poletti, Valentina, et al.
Publicado: (2018)

Pre-clinical Development of a Lentiviral Vector Expressing the Anti-sickling βAS3 Globin for Gene Therapy for Sickle Cell Disease
por: Poletti, Valentina, et al.
Publicado: (2018)

A single epidermal stem cell strategy for safe ex vivo gene therapy
por: Droz-Georget Lathion, Stéphanie, et al.
Publicado: (2015)

Muscle‐directed gene therapy corrects Pompe disease and uncovers species‐specific GAA immunogenicity
por: Eggers, Michelle, et al.
Publicado: (2021)

Re-discovering NK cell allo-reactivity in the therapy of solid tumors
por: Castagna, Luca, et al.
Publicado: (2016)

C/EBPδ regulates cell cycle and self-renewal of human limbal stem cells
por: Barbaro, Vanessa, et al.
Publicado: (2007)

Estimated Comparative Integration Hotspots Identify Different Behaviors of Retroviral Gene Transfer Vectors
por: Ambrosi, Alessandro, et al.
Publicado: (2011)

The Pharmacology of T Cell Therapies
por: Milone, Michael C., et al.
Publicado: (2018)

Biosafety Studies of a Clinically Applicable Lentiviral Vector for the Gene Therapy of Artemis-SCID
por: Charrier, Sabine, et al.
Publicado: (2019)

Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
por: Izmiryan, Araksya, et al.
Publicado: (2018)

A systems pharmacology model for gene therapy in sickle cell disease
por: Zheng, Bo, et al.
Publicado: (2021)

Genome-Wide Analysis of Alpharetroviral Integration in Human Hematopoietic Stem/Progenitor Cells
por: Moiani, Arianna, et al.
Publicado: (2014)

Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells
por: Turchiano, Giandomenico, et al.
Publicado: (2014)

Multiple Integrated Non-clinical Studies Predict the Safety of Lentivirus-Mediated Gene Therapy for β-Thalassemia
por: Lidonnici, Maria Rosa, et al.
Publicado: (2018)

The GATA1-HS2 Enhancer Allows Persistent and Position-Independent Expression of a β-globin Transgene
por: Miccio, Annarita, et al.
Publicado: (2011)

Correction: Genomic Analysis of Sleeping Beauty Transposon Integration in Human Somatic Cells
por: Turchiano, Giandomenico, et al.
Publicado: (2020)

Pharmacological therapy for amblyopia
por: Singh, Anupam, et al.
Publicado: (2017)

Why small particle fixed dose triple therapy? An excursus from COPD pathology to pharmacological treatment evolution
por: Braido, Fulvio, et al.
Publicado: (2022)

Pharmacological and Non-pharmacological Therapies of Cognitive Impairment in Multiple Sclerosis
por: Miller, Elżbieta, et al.
Publicado: (2018)

Optimized pharmacological control over the AAV-Gene-Switch vector for regulable gene therapy
por: Cheng, Shi, et al.
Publicado: (2021)

Pharmacological therapy of osteoporosis
por: Montalcini, T, et al.
Publicado: (2010)

Pharmacological limitations of phage therapy
por: Nilsson, Anders S.
Publicado: (2019)

Pharmacology of testosterone replacement therapy preparations
por: Shoskes, Jennifer J., et al.
Publicado: (2016)

Pharmacologic therapies for diabetic retinopathy and diabetic macular edema
por: Rechtman, Ehud, et al.
Publicado: (2007)

Mitochondrial Genetic Disorders: Cell Signaling and Pharmacological Therapies
por: Djouadi, Fatima, et al.
Publicado: (2019)

Clinical Pharmacology Perspectives for Adoptive Cell Therapies in Oncology
por: Huang, Weize, et al.
Publicado: (2022)

Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome
por: Felice, Barbara, et al.
Publicado: (2009)

Overview of Pharmacologic Therapy for the Treatment of Dyslipidemia
por: Lipsy, Robert J.
Publicado: (2003)

Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms
por: Plescia, Fulvio, et al.
Publicado: (2021)

Pharmacologic Therapies for Pediatric Concussions
por: Halstead, Mark E.
Publicado: (2016)

Pharmacological advances in mitochondrial therapy
por: Singh, Aarti, et al.
Publicado: (2021)

The Brugada syndrome: pharmacological therapy
por: Giustetto, Carla, et al.
Publicado: (2023)

Genome-wide analysis of promoter and enhancer usage in hematopoietic stem cell differentiation
por: Miccio, Annarita, et al.
Publicado: (2013)

NK Cell Subset Redistribution during the Course of Viral Infections
por: Lugli, Enrico, et al.
Publicado: (2014)

The role of primary pharmacological therapy in acromegaly
por: de los Monteros, Ana Laura Espinosa, et al.
Publicado: (2013)

Process Pharmacology: A Pharmacological Data Science Approach to Drug Development and Therapy
por: Lötsch, Jörn, et al.
Publicado: (2016)

Assessment of Gene Variant Amenability for Pharmacological Chaperone Therapy with 1-Deoxygalactonojirimycin in Fabry Disease
por: Lukas, Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0vt4mds12989blqau9v88of5bl